|Articles|February 12, 2015
Biotec Services International Completes its Rebrand into PCI
PCI is pleased to announce that further to the acquisition in September 2014 of Biotec Services International, the company has rebranded as part of the PCI group.
Advertisement
PCI is pleased to announce that further to the acquisition in September 2014 of Biotec Services International, the company has rebranded as part of the PCI group. This rebrand expands PCI’s capability to deliver an integrated pharmaceutical service for global studies of investigational medicinal products and include manufacturing, packaging and labeling, QP and GMP consultancy, global distribution and returned drug management, as well as consultant services.
Read the full release here.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement